01:43 PM EST, 02/06/2025 (MT Newswires) -- Lipella Pharmaceuticals ( LIPO ) shares soared 79% after the company said Thursday it received a US Food and Drug Administration approval for an expanded access program for LP-310, an oral rinse formulation designed to treat oral lichen planus.

Over 82.1 million shares traded intraday versus a daily average of roughly 127,000.

TransCode Therapeutics ( RNAZ ) said Thursday that Cohort 3 of its Phase 1 clinical trial enrolled three patients and all have been dosed with TTX-MC138, its lead candidate. The dose administered to patients in the cohort was about double that of Cohort 2.

Shares jumped nearly 33% as intraday trading volume climbed to more than 11.7 million from a daily average of over 1.44 million.

Tapestry (TPR) reported Thursday higher fiscal Q2 non-GAAP earnings and net sales while raising its outlook for fiscal 2025.

Shares rose roughly 13%, with intraday trading volume rising to nearly 10.6 million, compared with a daily average of more than 4.87 million.

Price: 4.69, Change: +2.07, Percent Change: +79.05